Grandfield & Dodd’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441K | Sell |
6,314
-190
| -3% | -$13.3K | 0.03% | 144 |
|
|
2025
Q1 | $478K | Sell |
6,504
-1
| -0% | -$74 | 0.03% | 141 |
|
|
2024
Q4 | $426K | Sell |
6,505
-921
| -12% | -$60.3K | 0.03% | 150 |
|
|
2024
Q3 | $579K | Sell |
7,426
-1,455
| -16% | -$113K | 0.03% | 134 |
|
|
2024
Q2 | $693K | Sell |
8,881
-331
| -4% | -$25.8K | 0.04% | 120 |
|
|
2024
Q1 | $624K | Sell |
9,212
-570
| -6% | -$38.6K | 0.04% | 126 |
|
|
2023
Q4 | $659K | Sell |
9,782
-1,055
| -10% | -$71.1K | 0.05% | 124 |
|
|
2023
Q3 | $734K | Sell |
10,837
-869
| -7% | -$58.8K | 0.05% | 119 |
|
|
2023
Q2 | $838K | Sell |
11,706
-769
| -6% | -$55K | 0.06% | 111 |
|
|
2023
Q1 | $866K | Sell |
12,475
-189
| -1% | -$13.1K | 0.06% | 112 |
|
|
2022
Q4 | $859K | Sell |
12,664
-1
| -0% | -$68 | 0.06% | 110 |
|
|
2022
Q3 | $690K | Sell |
12,665
-493
| -4% | -$26.9K | 0.06% | 115 |
|
|
2022
Q2 | $870K | Hold |
13,158
| – | – | 0.07% | 106 |
|
|
2022
Q1 | $870K | Sell |
13,158
-399
| -3% | -$26.4K | 0.06% | 114 |
|
|
2021
Q4 | $790K | Sell |
13,557
-713
| -5% | -$41.5K | 0.05% | 116 |
|
|
2021
Q3 | $860K | Buy |
+14,270
| New | +$860K | 0.06% | 109 |
|